GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Urologix Inc (OTCPK:ULGX) » Definitions » Total Inventories

Urologix (Urologix) Total Inventories : $1.32 Mil (As of Mar. 2015)


View and export this data going back to 1996. Start your Free Trial

What is Urologix Total Inventories?

Urologix's total inventories for the quarter that ended in Mar. 2015 was $1.32 Mil. Urologix's average total inventories from the quarter that ended in Dec. 2014 to the quarter that ended in Mar. 2015 was $1.32 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Urologix's Net-Net Working Capital per share for the quarter that ended in Mar. 2015 was $-0.51.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Urologix's Days Inventory for the three months ended in Mar. 2015 was 81.17.

Inventory Turnover measures how fast the company turns over its inventory within a year. Urologix's Inventory Turnover for the quarter that ended in Mar. 2015 was 1.12.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Urologix's Inventory-to-Revenue for the quarter that ended in Mar. 2015 was 0.47.


Urologix Total Inventories Historical Data

The historical data trend for Urologix's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Urologix Total Inventories Chart

Urologix Annual Data
Trend Jun05 Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.50 1.13 1.45 1.57 1.40

Urologix Quarterly Data
Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.32 1.40 1.31 1.32 1.32

Urologix Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Urologix  (OTCPK:ULGX) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Urologix's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2015 is

Net-Net Working Capital Per Share (Q: Mar. 2015 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.492+0.75 * 1.392+0.5 * 1.319-13.086
-0-0)/21.282
=-0.51

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Urologix's Days Inventory for the three months ended in Mar. 2015 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2015 )/Cost of Goods Sold (Q: Mar. 2015 )*Days in Period
=1.321/1.485*365 / 4
=81.17

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Urologix's Inventory Turnover for the quarter that ended in Mar. 2015 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2015 ) / Average Total Inventories (Q: Mar. 2015 )
=1.485 / 1.321
=1.12

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Urologix's Inventory to Revenue for the quarter that ended in Mar. 2015 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2015 ) / Revenue (Q: Mar. 2015 )
=1.321 / 2.796
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Urologix Total Inventories Related Terms

Thank you for viewing the detailed overview of Urologix's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Urologix (Urologix) Business Description

Traded in Other Exchanges
N/A
Address
14405 21st Avenue North, Suite 110, Minneapolis, MN, USA, 55447
Urologix Inc is a United States-based company engaged in the development, manufacturing, and marketing of minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The firm markets the Cooled ThermoTherapy (CTC) product line and the Prostiva Radio Frequency (RF) Therapy System (Prostiva). The CTC produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva delivers radio frequency energy directly into the prostate destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH voiding symptoms. The CTC product line includes the CoolWave and Targis Control Units and the CTC Advance catheter.
Executives
Emery Sidney W Jr director C/O QUALIGEN THERAPEUTICS, INC., 2042 CORTE DEL NOGAL, CARLSBAD CA 92011
Patrick D Spangler director 14405 21ST AVENUE NORTH, MINNEAPOLIS MN 55447
Gregory Fluet director, officer: CEO 14405 21ST AVENUE NORTH, MINNEAPOLIS MN 55447
William M Moore director
Guy C Jackson director C/O EPICEPT CORPORATION, 777 OLD SAW MILL ROAD, TARRYTOWN NY 10591
Daniel J Starks director ONE ST JUDE MEDICAL DRIVE, ST PAUL MN 55117
Claude Tihon officer: Chief Technology Officer
Bobby Ivan Griffin director 1326 SPRING VALLEY RD GOLDEN VALLEY PA 55422
David A Montecalvo officer: VP, Product Dev. & Operations 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Susan Bartlett Foote director 649 SUMMIT AVENUE, ST PAUL MN 55105

Urologix (Urologix) Headlines

From GuruFocus

Urologix Inc. (ULGX) CEO Stryker Jr Warren buys 16,900 Shares

By GuruFocus Research GuruFocus Editor 12-09-2009

Urologix Inc. Reports Operating Results (10-K)

By gurufocus 10qk 09-21-2009

Urologix Inc. (ULGX) CEO Stryker Jr Warren buys 5,200 Shares

By GuruFocus Research GuruFocus Editor 02-01-2011

Urologix Inc. (ULGX) CEO Stryker Jr Warren buys 3,100 Shares

By GuruFocus Research GuruFocus Editor 12-07-2009

Urologix Inc. Reports Operating Results (10-K)

By gurufocus 10qk 09-17-2010